Jump to content

PubMed RSS Feed - -Granulomatous rosacea-like dermatitis under therapy with tofacitinib


Recommended Posts

Hautarzt. 2021 Mar 24. doi: 10.1007/s00105-021-04793-6. Online ahead of print.


The case of a 32-year-old female with ulcerative colitis who developed severe papulopustular dermatitis while undergoing treatment with the Janus kinase (JAK) inhibitor tofacitinib. Despite intensive topical therapy, treatment with oral corticosteroids and oral doxycycline was unable to achieve sufficient improvement. Hence, tofacitinib treatment needed to be discontinued. It is well known that the class of JAK inhibitors can cause infectious and allergic cutaneous side effects. However, sterile papulopustular dermatitis as a side-effect has rarely been reported to date.

PMID:33760960 | DOI:10.1007/s00105-021-04793-6

{url} = URL to article

Full Text

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Create New...

Important Information

Terms of Use